You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Professional Issues Articles
Popular Professional Issues Articles
Highly Recommended Professional Issues Articles
Send a link to this page to your friends and colleagues.
Now Pfizer, the drug's manufacturer, has taken a deep breath, closed down the Indiana plant where Exubera was made, said goodbye to $2.8 billion dollars, and placed about 700 workers on paid leave.
The company is returning its Exubera rights to Nektar, its partner in the Exubera debacle, and will work with doctors over the next three months to switch Exubera patients to other diabetes treatments.
As far as another inhalable insulin? Don't hold your breath. Way back in June of 1998, Diabetes Health editor-in-chief Scott King told the Wall Street Journal, "I don't think anyone understands the lungs enough to use them as another pathway to take medicine, except maybe with a lung condition like asthma. I'd be very cautious and see how Phase II and Phase III come out." Apparently he was right.
Source: Forbes; Reuters, October 2007
Oct 31, 2007
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.